Cargando…

Revisiting the IGF-1R as a breast cancer target

The type I insulin-like growth factor-1 receptor is a well-described target in breast cancer and multiple clinical trials examining insulin-like growth factor-1 receptor have been completed. Unfortunately, monoclonal antibodies and tyrosine kinase inhibitors targeting insulin-like growth factor-1 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekyalongo, Roudy Chiminch, Yee, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687252/
https://www.ncbi.nlm.nih.gov/pubmed/29152592
http://dx.doi.org/10.1038/s41698-017-0017-y